Intranasal Fentanyl for Pain Management

• Status: Unknown status
• Trial end date: 2012-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Goal of the research will be to demonstrate a reduction in reported pain following the atomization and intra-nasal administration of Fentanyl versus the reduction in pain achieved from intravenous Fentanyl. It is hypothesized that pain should be reduced following fentanyl administration using the intra-nasal atomization equal to the intravenous delivery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Genesys
• Treatments: Fentanyl

Criteria

Inclusion Criteria:

• Persons who meet the current State of Michigan County of Oakland and County of Genesee pre-hospital pain requiring analgesia.

• Examples of these patients would be those with fractures, kidney stones, or traumatic injuries, burns.

Exclusion Criteria:

• Patients who have compromised nasal pharynx such as those who have obvious fractures or epistaxis.

• Additionally patients who are in the supine position for cervical spine immobilization will be excluded.